Prosecution Insights
Last updated: October 25, 2026

Shanghai Microport Endovascular Medtech (Group) Co. Ltd.

Technology area: Medical Devices & Mechanical Engineering

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Shanghai Microport Endovascular Medtech (Group) Co. Ltd. currently has 1 pending office action within the Medical Devices & Mechanical Engineering technology area. This single active matter represents the company's current efforts to secure patent protection. The case is assigned to 1 distinct examiner, providing a centralized point of contact for the prosecution process.

The prosecution is occurring within 1 distinct art unit. This concentration suggests that the technology is classified within a specific mechanical or medical specialty. Because the portfolio is limited to 1 distinct art unit, the practitioner can focus on a consistent set of examination guidelines and prior art.

WOLF, MEGAN YARNALL is the busiest examiner for the portfolio, currently responsible for 1 busiest examiner pending action. As the sole examiner involved, WOLF, MEGAN YARNALL will have a decisive impact on the outcome of the company's current patent efforts. Understanding the specific preferences of this examiner is essential for success.

With 1 pending office action, the prosecution environment is highly streamlined. The practitioner can dedicate full attention to the specific concerns of the assigned examiner in the Medical Devices & Mechanical Engineering field. This focused approach is ideal for resolving rejections and advancing the application toward allowance.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
WOLF, MEGAN YARNALL 1 61.0% +39.1%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18550268 COVERED STENT AND MEDICAL DEVICE WOLF, MEGAN YARNALL —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18550268 COVERED STENT AND MEDICAL DEVICE WOLF, MEGAN YARNALL —

Top Art Units

Art UnitApps
3774 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18550268 COVERED STENT AND MEDICAL DEVICE WOLF, MEGAN YARNALL 3774 §103§112 Non-Final OA — Pending Sep 12, 2023

Managing Shanghai Microport Endovascular Medtech (Group) Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Shanghai Microport Endovascular Medtech (Group) Co. Ltd. have?

Shanghai Microport Endovascular Medtech (Group) Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Shanghai Microport Endovascular Medtech (Group) Co. Ltd. applications?

Megan Yarnall Wolf has the most, with 1 of Shanghai Microport Endovascular Medtech (Group) Co. Ltd.'s pending office actions.

What technology area are Shanghai Microport Endovascular Medtech (Group) Co. Ltd.'s patent applications in?

Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month